StockData
Cardiol Therapeutics Inc. logo

Cardiol Therapeutics Inc. (CRDL) KPIs and segments

CRDLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 31, 2026Score 5/30
$0.86−0.02 (-2.28%)

Close on Nov 20, 2026Market cap $86.48MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Cardiol Therapeutics's business

Coming soon

This tab will track the numbers specific to Cardiol Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?